PreMD Inc.Toronto, ON Canada
Company Description
PreMD aims to detect illness at its earliest stages. The diagnostic development company currently offers, or is developing, non-invasive tests designed to detect and monitor a range of diseases, including colorectal cancer, coronary artery disease, breast cancer, and lung cancer. PreMD aims to develop tests administrable from the doctor's office, or pharmacy, or even from a patient's home. Due to financing challenges, the company has put all of its clinical programs on hold and cut its staff to a minimum.
| 4211 Yonge St., Ste. 615 | Phone: +1-416-2223449 | http://www.premdinc.com |
| Toronto, ON M2P 2A9 | Fax: +1-416-2224533 | 
Map This Company |
| Canada |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
PreMD Inc. Rankings
Executives
| 6 executives listed for PreMD Inc.'s Toronto, ON location. | ||
| President, CEO, and Director | Brent Norton | |
|---|---|---|
| EVP Clinical and Regulatory Affairs | Michael Evelegh | |
| VP Corporate Development | Timothy Currie | |
Financials
| Company Type | PublicSingle Location |
|---|---|
| Fiscal Year-End | December |
| Employees | 18 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on PreMD Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
